Blog

Stay Current on all things IP by subscribing to our blog

Harness IP takes pride in our collective knowledge of intellectual property law and how it affects businesses and organizations across a range of industries. We also enjoy keeping up with the latest decisions from the prominent venues that affect IP law, including the Federal Circuit, the U.S. Supreme Court, and the PTAB. Our goal is to distill this knowledge into practical guidance that in-house counsel and others can use. We invite you to join our audience and enrich the discussion whenever possible.

July 7, 2025

U.S. Chemical & Life Science Patents Q2 Newsletter

More
June 30, 2025

5 Federal Circuit Patent Cases You Need To Know

More
June 26, 2025

Enablement, Anticipation, and Claim Strategy: Rethinking Biotech Patent Drafting Post-Agilent

More
June 23, 2025

Six Actions to Take to Ensure Your Trade Secret Stays Secret

More
June 23, 2025

Cannabis And Trademarks: Protecting Against Infringement

More
May 13, 2025

The Hypocrisy of ‘Delete IP’: Billionaire Frustrations Masquerading as Policy

More

shutterstock common sense | Intellectual Property Law Firm | Harness IP

August 11, 2016

PTAB Misapplied Common Sense in Finding Claims Obvious

By: Bryan K. Wheelock, Principal

August 11, 2016

District Court Correctly Added Inventors Who Contributed to at least one Claim Element

By: Bryan K. Wheelock, Principal

August 9, 2016

BRI Does Not Apply if Patent Expires Any Time During Reexamination Proceeding

By: Bryan K. Wheelock, Principal

August 9, 2016

Federal Circuit Vacates and Remands PTAB Obviousness Determination Not Supported by Adequate Reasoned Explanation

By: Bryan K. Wheelock, Principal

shutterstock 240614686 small e1453910269364 | Intellectual Property Law Firm | Harness IP

August 5, 2016

Federal Circuit Provides Ammunition to Patentees In Magnum Decision

By: Hemant M. Keskar, Principal

August 5, 2016

Sale and Offer for Sale Determined by Where “Substantial Activities of the Sales Transactions” Occur

By: Bryan K. Wheelock, Principal

August 4, 2016

Markush Group Closed to Unlisted Elements, but Open to Blends of Listed Elements

By: Bryan K. Wheelock, Principal

August 1, 2016

Information is Intangible, so Methods of Manipulating it are Abstract

By: Bryan K. Wheelock, Principal

shutterstock consistency is key | Intellectual Property Law Firm | Harness IP

August 1, 2016

Repeated and Consistent Usage, including in Rule 131 Declaration, Defines Term

By: Bryan K. Wheelock, Principal

August 1, 2016

Detailed Analysis of Specification and Prosecution History Revealed Meaning of Claims

By: Bryan K. Wheelock, Principal

Harness IP Intellectual Property Attorneys

July 28, 2016

Patent Drafters: Leaving Coining to the Mint

By: Bryan K. Wheelock, Principal

MP900399041 | Intellectual Property Law Firm | Harness IP

July 25, 2016

PTO Cannot Raise & Decide Unpatentability Theories Never Presented by the Petitioner

By: Bryan K. Wheelock, Principal

BioPharma banner 10 26 17 | Intellectual Property Law Firm | Harness IP

July 20, 2016

BioPharma Patents Quick Tips & News – July 2016

By: Leanne M. Rakers, Principal

July 18, 2016

Where’s My %$^&# Dollar?

By: Bryan K. Wheelock, Principal

shutterstock objection | Intellectual Property Law Firm | Harness IP

July 15, 2016

I Win? No Fair!

By: Bryan K. Wheelock, Principal

July 12, 2016

New After-Final Pilot Prosecution Program Allows Enhanced Patent Practice

By: Michael Gamble, Principal

Harness IP IP Litigation IPR Attorneys

July 11, 2016

Sale of Manufacturing Services Does Not Trigger On Sale Bar Under Pre-AIA §102

By: Bryan K. Wheelock, Principal

FINALREJECTION | Intellectual Property Law Firm | Harness IP

July 10, 2016

It Ain’t Over ‘Till It’s Over

By: Bryan K. Wheelock, Principal

July 6, 2016

And in the Alternative . . .

By: Bryan K. Wheelock, Principal

July 5, 2016

The Commercial Marketing Provisions of the Biologics Act are Mandatory

By: Bryan K. Wheelock, Principal